33058503
2020 Oct 15.</span
With great interests, I carefully read the article by Valli De Re et al. in a recent issue of Liver International.1 The authors conducted a cohort study assessing the associations of polymorphisms of IFNL4 and PDCD1 genes on 734 hepatitis C virus (HCV)-positive patients, including 461 cases with liver disease of varying severity and 273 patients with lymphoproliferative disorders. The author indicated that IFNÎ»4 expression might contribute to the development of HCV-related hepatocellular carcinoma (HCC), and an epistatic contribution of IFNL4 and PDCD1 in mixed cryoglobulinemia (MC). However, some concerns should be interpreted cautiously in light of the following issues.

